Anti-kir Antibodies For The Treatment Of Inflammatory And Autoimmune Disorders

Abstract

This invention relates to compounds that inhibit KIR2DL1, 2 and/or 3 polypeptide comprising compounds (e.g., anti-KIR2DL1, 2, and/or 3 antibodies) that neutralize NK cell inhibitory receptors and methods of using such compounds and compositions containing in the treatment and prevention of inflammatory or autoimmune disorders.


Claims
Owners (US)

Download Citation


Sign in to the Lens

Feedback